https://www.scmp.com/rss/513934/feed A series of stories focusing on the innovators, entrepreneurs and investors of Singapore’s dynamic tech start-up ecosystem. <!--/*--><![CDATA[/* ><!--*/ <!--td {border: 1px solid #cccccc;}br {mso-data-placement:same-cell;}--> /*--><!]]>*/ en https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com [Sponsored article] Some other founders might christen their start-ups with catchy single-word names, but Shawn Li chose to name his biomedical firm after the building where he gained his doctorate – at the National University of Singapore (NUS) bioengineering campus. The idea for the business was born amid Li’s graduate research into optoelectronics, which led him to discover a global need for an affordable, easy-to-use device to monitor infants for jaundice – a condition where a baby’s blood... https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3207218/deep-tech-biomedical-start-ups?utm_source=rss_feed https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3207218/deep-tech-biomedical-start-ups?utm_source=rss_feed Thu, 19 Jan 2023 04:00:13 +0000 [Sponsored article] Entrepreneur Piers Ingram knows the stakes are high for his clinical-stage biomedical start-up, which is working to help find cures for hard-to-treat autoimmune disease and cancers. The CEO and co-founder of Hummingbird Bioscience set up the company in Singapore with chief scientific officer Jerome Boyd-Kirkup seven years ago to develop precision biotherapeutic products – drug therapies made from living organisms. Ingram says his company is “still not there yet” in terms of... https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3200670/venture-capitalists-invest?utm_source=rss_feed https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3200670/venture-capitalists-invest?utm_source=rss_feed Wed, 30 Nov 2022 04:00:16 +0000 [The content of this article has been produced by our advertising partner.] It is said that necessity is the mother of invention. In that vein, the adversity faced by start-ups amid the Covid-19 pandemic can be seen as both a bane and a boon: either a fatal blow to revenues that could sink the business for good, or an opportunity to forge new successes by pivoting products via powerful collaborations. Subscribers to the latter mindset include Quah Zheng Wei, CEO and co-founder of verification... https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3196739/how-dynamic-business-collaborations-help-power-singapores-vibrant-start-ecosystem?utm_source=rss_feed https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3196739/how-dynamic-business-collaborations-help-power-singapores-vibrant-start-ecosystem?utm_source=rss_feed Mon, 24 Oct 2022 08:00:10 +0000 [Sponsored article] The rapid pace of medical innovation and transformation during the Covid-19 pandemic radically changed how Singapore-based investor Chik Wai Chiew imagined he and his company could have an impact on society. The CEO and executive director of Heritas Capital, a private-equity and venture-capital (VC) company, realised it was essential to make significant changes in how we tackle challenges that the world is facing. Be it trying to combat the spread of cancer or diabetes,... https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3196365/venture-capitalists-invest?utm_source=rss_feed https://www.scmp.com/presented/business/topics/singapore-asias-innovation-gateway-world/article/3196365/venture-capitalists-invest?utm_source=rss_feed Thu, 20 Oct 2022 04:00:14 +0000